A detailed history of Naples Money Management LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Naples Money Management LLC holds 2,068 shares of DMAC stock, worth $9,843. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,068
Previous 2,978 30.56%
Holding current value
$9,843
Previous $8.79 Million 1.37%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.8 - $4.49 $2,548 - $4,085
-910 Reduced 30.56%
2,068 $8.67 Million
Q1 2024

Apr 30, 2024

SELL
$2.58 - $3.23 $2,322 - $2,907
-900 Reduced 23.21%
2,978 $8.25 Million
Q4 2023

Jan 31, 2024

BUY
$2.05 - $2.99 $7,949 - $11,595
3,878 New
3,878 $11 Million

Others Institutions Holding DMAC

About DiaMedica Therapeutics Inc.


  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $126M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track This Portfolio

Track Naples Money Management LLC Portfolio

Follow Naples Money Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Naples Money Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naples Money Management LLC with notifications on news.